Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study to Analyze the Outcomes of Subjects Who - Based Upon Their Sufficiently Elevated Risk for the Development of Pancreatic Adenocarcinoma- Elect to Undergo Early Detection Testing

NCT02206360 is registered in ClinicalTrials.gov with White Plains Hospital as lead sponsor.

NCT NCT02206360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02206360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study to Analyze the Outcomes of Subjects Who - Based Upon Their Sufficiently Elevated Risk for the Development of Pancreatic Adenocarcinoma- Elect to Undergo Early Detection Testing
Lead sponsor
White Plains Hospital
Phase
Observational
Overall status
Completed
Start date
April 30, 2014
Completion date
August 31, 2024
Enrollment
181 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca 1/2, familial atypical multiple mole melanoma, familial pancreatic cancer, fammm, hereditary pancreatitis, hnpcc, lynch syndrome, pancreas cancer, pancreatic adenocarcinoma, pancreatic cancer, peutz jeghers syndrome